Schroder Investment Management Group Staar Surgical CO Transaction History

Schroder Investment Management Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$46.82 - $76.2 $300,163 - $488,518	6,411 Added 47.87%	19,803 $961,000
Q3 2022 Nov 10, 2022	BUY	$70.55 - $111.58 $944,805 - $1.49 Million	13,392 New	13,392 $945,000
Q4 2021 Feb 14, 2022	SELL	$88.02 - $127.79 $417,566 - $606,235	-4,744 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$122.75 - $162.68 $296,195 - $392,546	-2,413 Reduced 33.72%	4,744 $610,000
Q2 2021 Aug 13, 2021	SELL	$105.76 - $154.96 $139,285 - $204,082	-1,317 Reduced 15.54%	7,157 $1.09 Million
Q1 2021 May 17, 2021	BUY	$78.5 - $126.48 $665,209 - $1.07 Million	8,474 New	8,474 $893,000

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.